Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series
Turkish Journal of Internal Medicine · 2022
DOI: 10.46310/tjim.1009709 ↗Abstrakt
Severe thrombocytopenia is a cause of morbidity and mortality for patients with COVID-19 infection. The common causes of thrombocytopenia in these patients are; sepsis, drug-associated, disseminated intravascular coagulation (DIC), heparin-associated thrombocytopenia (HIT), microangiopathic hemolytic anemia (MAHA). Recently, cases of COVID-19 infection-associated Immune thrombocytopenic purpura (ITP) have been reported in the literature. In our study, we will present our case series consisting of 10 patients associated with COVID-19
EUVIMED